BROSSARD, Quebec, Feb. 14, 2018 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), wishes to comment on recent trading by Dundee Corporation (“Dundee”).
On February 2nd, 2018, Dundee, through its wholly-owned subsidiary Dundee Resources Limited, disposed an aggregate of 2,026,000 common shares (“Shares”) of the Corporation on the TSX Venture Exchange. As stated in the February 8th, 2018 news release from Dundee, the Shares were initially acquired for investment purposes only. As an insider of DIAGNOS, in accordance with regulatory requirements, Dundee also filed an early warning report on SEDAR in respect of the trade. DIAGNOS was not made aware of the decision to dispose the Shares prior to the sale.